We have two new exciting chemical biology/proteomics postdoc positions available in our group. If you're interested in drug target discovery at the interface between industry & academia please apply! Deadline 17th February 2022.

1: - Postdoctoral Scientist - Cancer Biology & Systems Pharmacology

2: - Oxford-BMS Postdoctoral Fellow – Chemical Biology & Proteomics

Congratulations to our friends at Promega & SGC-UNC who have developed a platform to comprehensively study CDK inhibitor target engagement across the whole family in live cells. Very excited we could contribute - check out the full paper now published in Nature Communications:

#chemicalprobes #targetengagement #drugdiscovery #CDK

Congratulations to Jenny & Adan on their work on covalent inhibitors of DUBs now published in J. Med. Chem.

This has been a great collaboration between the labs of Ed Tate, Benedict Kessler, Olivier Feron, and the Huber group.